Haematological Disorders Iron deficiency anaemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Aged 18 to 50 years Hb level between 8.0 - 12.9 g/l for men and 8.0-11.9 g/l for women All sex groups (Men and Women) No history of vitamins or mineral supplements in the last 30 days No signs of impaired organ function (kidney and liver) Free from chronic illness (Hypertension, Diabetes, TB, HIV/AIDS, Any form of Cancer) No blood donation or received in the past 6 months prior the study Consent voluntarily to participate in the clinical trial
Exclusion criteria
Exclusion criteria: Vulnerable population (pregnant women, nursing mothers, children below 18 years) will be excluded in the study Individuals not permanent residents of the trial site Hypersensitivity to any drug or herbal products History of a presence of dyspepsia, gastric ulcer or duodenal ulcer History of autoimmune disorders e.g. systemic lupus erythematous, haemolytic anaemia History of psychiatric disorders Participation in any investigational product within 90 days prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of individual anaemic state to non-anaemic (as per definition);Actual change of Hb level at specified time points as compared to Hb value recorded at baseline | — |
Countries
Tanzania
Contacts
Principal Research scientist/NIMR, Tanzania